Administration of spironolactone, a selective MR antagonist, counteracted stress-induced mGlu2 suppression and the related development of depressive-like behavior, implicating rapid action of glucocorticoids via a receptor that is known to modulate glutamate release [20]
On average though, you should expect to see real results with about four months of weekly injections
Here, we will witness one of the most impressive natural spectacles: the majestic flight of the Andean condors over the second deepest canyon in the world (4,160 meters)
The market has seen strong traction from newer therapies such as: Eli Lillys Mounjaro (tirzepatide), launched in the UK in February 2024 and made available via the NHS in March 2025 Novo Nordisks Wegovy (semaglutide), introduced in the UK in September 2023 through specialist NHS weight-management services While these newer molecules dominate headlines, liraglutide remains a widely prescribed and proven therapy, and Biocons entry offers a more affordable alternativea key differentiator in public healthcare systems
Instead of advancing doses on the standard 4-week timeline, some patients benefit from extending their current dose for 56 weeks before stepping up
B5 B6
